Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review
出版年份 2011 全文链接
标题
Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review
作者
关键词
-
出版物
BREAST CANCER RESEARCH AND TREATMENT
Volume 132, Issue 3, Pages 895-915
出版商
Springer Nature
发表日期
2011-11-03
DOI
10.1007/s10549-011-1837-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Is the Ki-67 labelling index ready for clinical use?
- (2011) W. Jonat et al. ANNALS OF ONCOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer
- (2010) A. DeCensi et al. ANNALS OF ONCOLOGY
- Variables with time-varying effects and the Cox model: Some statistical concepts illustrated with a prognostic factor study in breast cancer
- (2010) Carine A Bellera et al. BMC Medical Research Methodology
- MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups
- (2010) Mohammed A. Aleskandarany et al. BREAST CANCER RESEARCH AND TREATMENT
- Recent Advances
- (2010) W. Chris Taylor et al. CANCER JOURNAL
- Prognostic Value of a Combined ER, PgR, Ki67, HER2 Immunohistochemical (IHC4) Score and Comparison with the GHI Recurrence Score – Results from TransATAC.:
- (2010) J. Cuzick et al. CANCER RESEARCH
- Personalized treatment of early-stage breast cancer: Present concepts and future directions
- (2010) Nadia Harbeck et al. CANCER TREATMENT REVIEWS
- BCIRG 001 Molecular Analysis: Prognostic Factors in Node-Positive Breast Cancer Patients Receiving Adjuvant Chemotherapy
- (2010) C. Dumontet et al. CLINICAL CANCER RESEARCH
- Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer
- (2010) T. Tanei et al. EJSO
- Current and emerging biomarkers in breast cancer: prognosis and prediction
- (2010) Marion T Weigel et al. ENDOCRINE-RELATED CANCER
- Comparative validation of the SP6 antibody to Ki67 in breast cancer
- (2010) L. Zabaglo et al. JOURNAL OF CLINICAL PATHOLOGY
- Cancer Biomarkers: Can We Turn Recent Failures into Success?
- (2010) E. P. Diamandis JNCI-Journal of the National Cancer Institute
- Predictive markers of anthracycline benefit: a prospectively planned analysis of the UK National Epirubicin Adjuvant Trial (NEAT/BR9601)
- (2010) John MS Bartlett et al. LANCET ONCOLOGY
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
- Does Analysis of Biomarkers in Tumor Cells in Lymph Node Metastases Give Additional Prognostic Information in Primary Breast Cancer?
- (2010) Anna-Karin Falck et al. WORLD JOURNAL OF SURGERY
- Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
- (2010) Fiona M. Blows et al. PLOS MEDICINE
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
- (2009) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer
- (2009) Robin L. Jones et al. BREAST CANCER RESEARCH AND TREATMENT
- Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
- (2009) S Mallett et al. BRITISH JOURNAL OF CANCER
- Predictive signatures for chemotherapy sensitivity in breast cancer: Are they ready for use in the clinic?
- (2009) Hervé Bonnefoi et al. EUROPEAN JOURNAL OF CANCER
- Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma
- (2009) Alessandra Capodanno et al. HUMAN PATHOLOGY
- Disease-Free Survival According to Degree ofHER2Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial
- (2009) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 Expression and Docetaxel Efficacy in Patients With Estrogen Receptor–Positive Breast Cancer
- (2009) Frédérique Penault-Llorca et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
- (2009) R. M. Simon et al. JNCI-Journal of the National Cancer Institute
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis
- (2009) Reiki Nishimura et al. Breast Cancer
- Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer
- (2008) C. Andreetta et al. ANNALS OF ONCOLOGY
- Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial
- (2008) M. Untch et al. ANNALS OF ONCOLOGY
- Expression of centromere protein F (CENP-F) associated with higher FDG uptake on PET/CT, detected by cDNA microarray, predicts high-risk patients with primary breast cancer
- (2008) Shigeto Ueda et al. BMC CANCER
- Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients
- (2008) R. Stuart-Harris et al. BREAST
- Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial
- (2008) Matthew J. Ellis et al. BREAST CANCER RESEARCH AND TREATMENT
- NEAT: National Epirubicin Adjuvant Trial – toxicity, delivered dose intensity and quality of life
- (2008) H M Earl et al. BRITISH JOURNAL OF CANCER
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
- (2008) C. M. Sturgeon et al. CLINICAL CHEMISTRY
- Type 1 Receptor Tyrosine Kinase Profiles Identify Patients With Enhanced Benefit From Anthracyclines in the BR9601 Adjuvant Breast Cancer Chemotherapy Trial
- (2008) John M.S. Bartlett et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole
- (2008) Giuseppe Viale et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Significance of Nottingham Histologic Grade in Invasive Breast Carcinoma
- (2008) Emad A. Rakha et al. JOURNAL OF CLINICAL ONCOLOGY
- Phosphorylated ERα, HIF-1α, and MAPK Signaling As Predictors of Primary Endocrine Treatment Response and Resistance in Patients With Breast Cancer
- (2008) Daniele Generali et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive Value of Tumor Ki-67 Expression in Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer
- (2008) Giuseppe Viale et al. JNCI-Journal of the National Cancer Institute
- Outcome Prediction for Estrogen Receptor-Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics
- (2008) M. J. Ellis et al. JNCI-Journal of the National Cancer Institute
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now